Filing Details

Accession Number:
0000899243-22-015802
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-27 20:36:18
Reporting Period:
2022-04-25
Accepted Time:
2022-04-27 20:36:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851657 Vaxxinity Inc. VAXX Medicinal Chemicals & Botanical Products (2833) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
896839 United Biomedical Inc 25 Davids Drive
Hauppauge NY 11788
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-04-25 8,038 $3.37 5,193,454 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 4,212,495 Indirect Held by United Biomedical Inc., Asia
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported is a weighted average price.
  3. Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.